Cannabist (OTCMKTS:CBSTF) Price Target Cut to $0.75

Cannabist (OTCMKTS:CBSTF) had its price objective reduced by equities research analysts at Roth Mkm from $1.00 to $0.75 in a report released on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Roth Mkm’s price objective suggests a potential upside of 180.85% from the stock’s previous close.

Cannabist Stock Up 4.7 %

CBSTF traded up $0.01 during midday trading on Friday, hitting $0.27. 1,547,591 shares of the company traded hands, compared to its average volume of 1,561,452. Cannabist has a 52-week low of $0.21 and a 52-week high of $1.50.

Cannabist Company Profile

The Cannabist Company Holdings Inc engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. The company provides flower, concentrates, edibles, and/or accesories, and medicinal cannabinoid capsules and tablets, as well as confections, chocolate, drink mixes, condiments, kief, shatter, and wax/crumble, under the Seed & Strain, Classix, and Triple Seven brand names.